Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab, India.
Department of Psychiatry, AIIMS, Jodhpur, Rajasthan, India.
Indian J Psychiatry. 2014 Oct;56(4):371-6. doi: 10.4103/0019-5545.146520.
The study aimed to evaluate the prevalence of cardiovascular risk (CVR) factors and metabolic syndrome (MS) in patients with schizophrenia.
By consecutive sampling, 143 patients (of age ≥ 20 years), out of total 159 patients with schizophrenia admitted to the inpatient unit were evaluated for the coronary heart disease (CHD) risk as per Framingham (10-year all CHD events) function/risk equation and systematic coronary risk evaluation (SCORE) - 10-year cardiovascular mortality risk (CMR). Prevalence of MS was estimated by using the consensus definition.
Fifty-two (36.4%) patients fulfilled the criteria for MS. 10-year CHD risk was 1.65%, and 10-year CMR was 1.39%. Compared to females, males had higher Framingham score (1.96 ± 2.74 vs. 1.09 ± 0.41, U value 1987.5*, P < 0.05).
Patients of schizophrenia have a high prevalence of MS and CVR factors. Hence, there is a need to screen the patient of schizophrenia for the same and manage the same as early as possible during the course of illness.
本研究旨在评估精神分裂症患者心血管风险(CVR)因素和代谢综合征(MS)的患病率。
通过连续抽样,对 159 名住院精神分裂症患者中的 143 名(年龄≥20 岁)患者,根据 Framingham(10 年所有冠心病事件)函数/风险方程和系统性冠状动脉风险评估(SCORE)-10 年心血管死亡率风险(CMR)评估冠心病(CHD)风险。采用共识定义估计 MS 的患病率。
52 名(36.4%)患者符合 MS 标准。10 年 CHD 风险为 1.65%,10 年 CMR 为 1.39%。与女性相比,男性的 Framingham 评分更高(1.96 ± 2.74 比 1.09 ± 0.41,U 值 1987.5*,P < 0.05)。
精神分裂症患者 MS 和 CVR 因素的患病率较高。因此,有必要对精神分裂症患者进行筛查,并在疾病过程中尽早进行管理。